Hyderabad-based Bharat Biotech International Limited, the manufacturer behind India's Covaxin, issued a statement addressing an "inadvertent mistake" in its patent filings related to the COVID-19 vaccine. The company admitted to not crediting the Indian Council of Medical Research (ICMR) as a co-owner in patent applications filed in India, the United States, and Europe. This development contradicted earlier claims by the Union health ministry that intellectual property rights to Covaxin were jointly owned.